Cargando…
First-in-human Phase 1 CRISPR Gene Editing Cancer Trials:Are We Ready?
A prospective first-in-human Phase 1 CRISPR gene editing trial in the United States for pa-tients with melanoma, synovial sarcoma, and multiple myeloma offers hope that gene editing tools may usefully treat human disease. An overarching ethical challenge with first-in-human Phase 1 clinical trials,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769084/ https://www.ncbi.nlm.nih.gov/pubmed/29173170 http://dx.doi.org/10.2174/1566523217666171121165935 |